Mechanisms of the free fatty acid-induced increase in hepatic glucose production
- PMID: 12676648
- DOI: 10.1152/ajpendo.00033.2003
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
Abstract
The associations between obesity, insulin resistance, and type 2 diabetes mellitus are well documented. Free fatty acids (FFA), which are often elevated in obesity, have been implicated as an important link in these associations. Contrary to muscle glucose metabolism, the effects of FFA on hepatic glucose metabolism and the associated mechanisms have not been extensively investigated. It is still controversial whether FFA have substantial effects on hepatic glucose production, and the mechanisms responsible for these putative effects remain unknown. We review recent progress in this area and try to clarify controversial issues regarding the mechanisms responsible for the FFA-induced increase in hepatic glucose production in the postabsorptive state and during hyperinsulinemia.
Similar articles
-
Time-dependent effects of fatty acids on skeletal muscle metabolism.J Cell Physiol. 2007 Jan;210(1):7-15. doi: 10.1002/jcp.20811. J Cell Physiol. 2007. PMID: 17013887 Review.
-
Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.J Endocrinol. 2007 Nov;195(2):323-31. doi: 10.1677/JOE-07-0005. J Endocrinol. 2007. PMID: 17951543
-
Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.Exp Clin Endocrinol Diabetes. 2003 Aug;111(5):246-50. doi: 10.1055/s-2003-41284. Exp Clin Endocrinol Diabetes. 2003. PMID: 12951628 Review.
-
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1089-97. doi: 10.1152/ajpendo.00306.2005. Epub 2006 Jan 3. Am J Physiol Endocrinol Metab. 2006. PMID: 16390863
-
In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.Clin Endocrinol (Oxf). 2005 Oct;63(4):442-9. doi: 10.1111/j.1365-2265.2005.02362.x. Clin Endocrinol (Oxf). 2005. PMID: 16181237 Clinical Trial.
Cited by
-
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.Diabetes Metab J. 2024 May;48(3):327-339. doi: 10.4093/dmj.2023.0350. Epub 2024 Feb 2. Diabetes Metab J. 2024. PMID: 38310873 Free PMC article. Review.
-
The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects.Diabetologia. 2004 Apr;47(4):652-9. doi: 10.1007/s00125-004-1374-y. Diabetologia. 2004. PMID: 15298342 Clinical Trial.
-
Statin use in the metabolic syndrome.Curr Atheroscler Rep. 2005 Feb;7(1):17-21. doi: 10.1007/s11883-005-0070-9. Curr Atheroscler Rep. 2005. PMID: 15683597 Review.
-
CPT1a-Dependent Long-Chain Fatty Acid Oxidation Contributes to Maintaining Glucagon Secretion from Pancreatic Islets.Cell Rep. 2018 Jun 12;23(11):3300-3311. doi: 10.1016/j.celrep.2018.05.035. Cell Rep. 2018. PMID: 29898400 Free PMC article.
-
Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats.Diabetol Metab Syndr. 2024 Sep 11;16(1):218. doi: 10.1186/s13098-024-01432-7. Diabetol Metab Syndr. 2024. PMID: 39261952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources